Artesunate-loaded Fe3O4 nanoparticles: A novel approach for combating 4T1 breast cancer cells in vitro and in vivo

Articles in Press

Document Type : Research Paper

Authors

1 Department of Immunology, Faculty of Medicine, Tarbiat Modares University, Tehran, Iran

2 Immunology Board for Transplantation and Cell-Based Therapeutics (Immuno_TACT), Universal Scientific Education and Research Network (USERN), Tehran, Iran

3 Department of Biophysics, Nanobiotechnology Faculty of Biological Sciences Tarbiat Modares UniversityTehran, Iran

4 Department of Pathology, School of Medicine, Alborz University of Medical Sciences, Karaj,Iran

5 Department of Biostatistics and Epidemiology, School of Public Health, Babol University of Medical Sciences, Babol, Iran

6 Department of Immunology, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran

10.22038/nmj.2024.76265.1864

Abstract

Objective(s): Breast cancer is one of the most common cancers among women, and current treatments are inadequate due to unwarranted side effects and lack of specificity resulting in off target consequences. Artesunate is a synthetic anti-malarial drug that exerts inhibitory effects on cancer cell lines via apoptosis and has been used treating some cancers. This study investigated the anticancer effects of Fe3O4 magnetic nanoparticles conjugated with chitosan, polyethylene glycol, folic acid, and artesunate in vivo and in vitro.
Materials and Methods: Nanoparticles were synthesized by co-precipitation; morphology and size were determined by scanning electron microscopy (SEM), and the presence of the components was verified by nanoscale Fourier transform infrared spectroscopy (FTIR).  4T1 murine mammary tumor cells were treated with nanoparticles, and cell viability was determined by MTT assay. 4T1 cells were also subcutaneously injected into BALB/c mice, and magnetic resonance imaging was carried out two weeks later to determine tumor size among the groups.  Interferon gamma (IFN-γ) and IL-4 levels (in splenocytes culture supernatant) were measured by ELISA, and tumors, surrounding tissues, and mouse livers were histopathologically studied. 
Results: The nanoparticle made in this article had good anticancer effects and caused apoptosis in cancer cells in breast cancer, and also strengthened the cellular immune system and further increased interferon gamma and increased the half-life of mice with cancer, while this nanoparticle It did not have the side effects of chemotherapy drugs.
Conclusion: Artesunate-containing nanoparticles decreased 4T1 cell viability and increased apoptosis to a greater extent than nanoparticles without the drug. In vivo, artesunate nanoparticles showed no toxicity and were more effective in decreasing tumor size than control. They were also associated with increased survival, increased IFN-γ, and decreased IL-4 levels in the spleen. The findings show the drug targets cancer  cells effectively with minimal side effects due to its herbal nature and targeted nano delivery. 

Keywords

References

1.     Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56(2):106–130. 
2.     Hamacher-Brady A, Stein HA, Turschner S, Toegel I, Mora R, Jennewein N, et al. Artesunate activates mitochondrial apoptosis in breast cancer cells via  iron-catalyzed lysosomal reactive oxygen species production. J Biol Chem. 2011;286(8):6587–6601. 
3.     Michaelis M, Kleinschmidt MC, Barth S, Rothweiler F, Geiler J, Breitling R, et al. Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell  lines. Biochem Pharmacol. 2010;79(2):130–136. 
4.     Singh N, B V. Case report of a laryngeal squamous cell carcinoma treated with artesunate. Arch Oncol. 2002;10. 
5.     Tran TH, Nguyen TD, Poudel BK, Nguyen HT, Kim JO, Yong CS, et al. Development and Evaluation of Artesunate-Loaded Chitosan-Coated Lipid Nanocapsule  as a Potential Drug Delivery System Against Breast Cancer. AAPS PharmSciTech. 2015;16(6):1307–1316. 
6.     Wang Y, Han Y, Yang Y, Yang J, Guo X, Zhang J, et al. Effect of interaction of magnetic nanoparticles of Fe₃O₄ and artesunate on  apoptosis of K562 cells. Int J Nanomedicine. 2011;6:1185–1192. 
7.     Stella B, Arpicco S, Peracchia MT, Desmaële D, Hoebeke J, Renoir M, et al. Design of folic acid-conjugated nanoparticles for drug targeting. J Pharm Sci. 2000;89(11):1452–1464. 
8.     Knop K, Hoogenboom R, Fischer D, Schubert US. Poly(ethylene glycol) in drug delivery: Pros and cons as well as potential  alternatives. Angew Chem Int Ed Engl. 2010;49(36):6288–6308. 
9.     Berger J, Reist M, Mayer JM, Felt O, Gurny R. Structure and interactions in chitosan hydrogels formed by complexation or  aggregation for biomedical applications. Eur J Pharm Biopharm  Off J  Arbeitsgemeinschaft fur Pharm Verfahrenstechnik eV. 2004;57(1):35–52. 
10.     Yallapu MM, Othman SF, Curtis ET, Gupta BK, Jaggi M, Chauhan SC. Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer  therapy. Biomaterials. 2011;32(7):1890–1905. 
11.     Wang J, Chen B, Chen J, Cai X, Xia G, Liu R, et al. Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles. Int J Nanomedicine. 2011;6:203–211. 
12.     Chen B, Lai B, Cheng J, Xia G, Gao F, Xu W, et al. Daunorubicin-loaded magnetic nanoparticles of Fe3O4 overcome multidrug resistance  and induce apoptosis of K562-n/VCR cells in vivo. Int J Nanomedicine. 2009;4:201–208. 
13.     Chertok B, Moffat BA, David AE, Yu F, Bergemann C, Ross BD, et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic  targeting of brain tumors. Biomaterials. 2008 Feb;29(4):487–496. 
14.     Chen D, Tang Q, Li X, Zhou X, Zang J, Xue W, et al. Biocompatibility of magnetic Fe₃O₄ nanoparticles and their cytotoxic effect on  MCF-7 cells. Int J Nanomedicine. 2012;7:4973–4982. 
15.     Dias AMM, Courteau A, Bellaye P-S, Kohli E, Oudot A, Doulain P-E, et al. Superparamagnetic Iron Oxide Nanoparticles for Immunotherapy of Cancers through  Macrophages and Magnetic Hyperthermia. Pharmaceutics. 2022;14(11):2388. 
16.     Jain KK. Role of nanobiotechnology in developing personalized medicine for cancer. Technol Cancer Res Treat. 200;4(6):645–650. 
17.     Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical  applications. Biomaterials. 2005;26(18):3995–4021. 
Nanomedicine Journal

Articles in Press, Accepted Manuscript
Available Online from 21 August 2024

Files

Share

How to cite

Statistics